These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31734955)

  • 1. Institutions for health care price setting and regulation: A comparative review of eight settings.
    Barber SL; Lorenzoni L; Ong P
    Int J Health Plann Manage; 2020 Mar; 35(2):639-648. PubMed ID: 31734955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pricing health services for purchasers--a review of methods and experiences.
    Waters HR; Hussey P
    Health Policy; 2004 Nov; 70(2):175-84. PubMed ID: 15364147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generic drug prices and policy in Australia: room for improvement? a comparative analysis with England.
    Mansfield SJ
    Aust Health Rev; 2014 Feb; 38(1):6-15. PubMed ID: 24480618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Less Than One-third of Hospitals Provide Compliant Price Transparency Information for Total Joint Arthroplasty Procedures.
    Burkhart RJ; Hecht CJ; Acuña AJ; Kamath AF
    Clin Orthop Relat Res; 2022 Dec; 480(12):2316-2326. PubMed ID: 35901439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International Price Comparisons of Anticancer Drugs: A Scheme for Improving Patient Accessibility.
    Jung JH; Kim DJ; Suh K; You J; Lee JH; Joung KI; Suh DC
    Int J Environ Res Public Health; 2021 Jan; 18(2):. PubMed ID: 33466893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pricing policies for generic medicines in Australia, New Zealand, the Republic of Korea and Singapore: patent expiry and influence on atorvastatin price.
    Roughead EE; Kim DS; Ong B; Kemp-Casey A
    WHO South East Asia J Public Health; 2018 Sep; 7(2):99-106. PubMed ID: 30136668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Getting the Price Right: Lessons for Medicare Price Negotiation from Peer Countries.
    Rand LZ; Kesselheim AS
    Pharmacoeconomics; 2022 Dec; 40(12):1131-1142. PubMed ID: 36348153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence-based decision-making in Asia-Pacific with rapidly changing health-care systems: Thailand, South Korea, and Taiwan.
    Jirawattanapisal T; Kingkaew P; Lee TJ; Yang MC
    Value Health; 2009; 12 Suppl 3():S4-11. PubMed ID: 20586980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unmanaged care: the need to regulate new reproductive technologies in the United States.
    Cohen CB
    Bioethics; 1997; 11(3-4):348-65. PubMed ID: 11654790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assistive technology pricing in Australia: is it efficient and equitable?
    Summers MP; Verikios G
    Aust Health Rev; 2018 Feb; 42(1):100-110. PubMed ID: 28160784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prices for generics in Australia - more competition might help.
    Bulfone L
    Aust Health Rev; 2009 May; 33(2):200-14. PubMed ID: 19563309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insurance linked to jobs -- system showing its age: the price of health.
    Uchitelle L
    N Y Times Web; 1991 May; ():A1, D23. PubMed ID: 11646246
    [No Abstract]   [Full Text] [Related]  

  • 14. Setting limits: a realistic assignment for the Medicare program?
    Kinney ED
    St Louis Univ Law J; 1989; 33(3):631-70. PubMed ID: 11650405
    [No Abstract]   [Full Text] [Related]  

  • 15. Real or perceived impediments to minimum pricing of alcohol in Australia: public opinion, the industry and the law.
    Chalmers J; Carragher N; Davoren S; O'Brien P
    Int J Drug Policy; 2013 Nov; 24(6):517-23. PubMed ID: 23773685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. If You Make Them Build It, They Still May Not Come.
    Kirkner RM
    Manag Care; 2018 Jun; 27(6):7-8. PubMed ID: 29989902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Price and income elasticities of demand for modern health care: the case of infant delivery in the Philippines.
    Schwartz JB; Akin JS; Popkin BM
    World Bank Econ Rev; 1988 Jan; 2(1):49-76. PubMed ID: 12282273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pricing and reimbursement of pharmaceuticals in the Czech Republic and Sweden.
    Davidova J; Praznovcova L; Lundborg CS
    Pharm World Sci; 2008 Jan; 30(1):57-64. PubMed ID: 17588212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Most Americans Do Not Believe That There Is An Association Between Health Care Prices And Quality Of Care.
    Phillips KA; Schleifer D; Hagelskamp C
    Health Aff (Millwood); 2016 Apr; 35(4):647-53. PubMed ID: 27044965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug price transparency initiative: A scoping review.
    Ahmad NS; Makmor-Bakry M; Hatah E
    Res Social Adm Pharm; 2020 Oct; 16(10):1359-1369. PubMed ID: 31987771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.